Entheon Biomedical Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Aug '25 Aug 15, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2019
Market Capitalization	1	1	1	2	32	31	Upgrade
Market Cap Growth	1.23%	109.89%	-66.67%	-94.44%	3.86%	-	Upgrade
Enterprise Value	1	1	0	2	28	29	Upgrade
Last Close Price	0.10	0.14	0.10	0.30	5.40	7.60	Upgrade
PS Ratio	-	-	2.36	9.35	-	-	Upgrade
PB Ratio	3.02	8.53	1.87	2.88	3.52	8.20	Upgrade
P/TBV Ratio	3.02	8.53	1.87	2.88	10.13	8.20	Upgrade
EV/Sales Ratio	-	-	0.84	8.04	-	-	Upgrade
Asset Turnover	-	-	0.43	0.04	-	-	Upgrade
Quick Ratio	26.09	3.54	4.11	4.67	2.24	4.00	Upgrade
Current Ratio	27.75	4.53	4.64	4.81	3.46	6.05	Upgrade
Return on Equity (ROE)	-98.74%	-137.90%	-64.49%	-42.66%	-125.03%	-231.39%	Upgrade
Return on Assets (ROA)	-58.79%	-70.93%	-33.41%	-41.88%	-71.06%	-44.49%	Upgrade
Return on Capital (ROIC)	-63.44%	-90.19%	-42.03%	-46.57%	-80.25%	-54.11%	Upgrade
Earnings Yield	-27.37%	-25.63%	-50.77%	-480.67%	-27.87%	-14.27%	Upgrade
FCF Yield	-	-28.68%	-60.91%	-110.26%	-16.72%	-9.27%	Upgrade
Buyback Yield / Dilution	-74.11%	-30.96%	-	-8.85%	-97.83%	-543.78%	Upgrade

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.